Identifying Molecular Determinants of Infertility in Men (MODIFY)

Launched by INSTITUTE FOR HUMAN DEVELOPMENT AND POTENTIAL (IHDP), SINGAPORE · Nov 21, 2023

Keywords

ClinConnect Summary

The clinical trial titled "Identifying Molecular Determinants of Infertility in Men" (MODIFY) aims to explore why some men have difficulty fathering children when the cause is not clear. Researchers are looking to find specific tiny molecules called small non-coding RNAs (sncRNAs) that could help identify infertility issues. By understanding these factors better, the goal is to create a more accurate way to diagnose male infertility.

To participate in this study, men aged 21 to 50 who are fluent in English and willing to follow the study's guidelines can apply. However, those who have certain health conditions, like tuberculosis or severe mental health issues, or who are dealing with substance abuse, will not be eligible. Participants can expect to contribute to important research that may help many others facing infertility challenges in the future. This study is currently recruiting participants, making it a great opportunity for eligible men to make a difference in the understanding of male infertility.

Gender

MALE

Eligibility criteria

• • Inclusion Criteria
• • Male, aged 21 - 50 years old
• • Proficient in English language
• • Willing to comply to study protocol
• • Able to provide written informed consent
• • Exclusion Criteria
• • Current and/or previous diagnosis of Tuberculosis, Acquired immunodeficiency syndrome (AIDs), and other sexually transmitted diseases
• • Experiencing severely limited mobility (eg. Wheelchair bound, need walking aid)
• • Diagnosed with severe unstable mental conditions (eg. Dementia, or cognitive impairment)
• • Alcohol or drug abuse